MICHAEL STELLMACHER: Open Payments
NPI 1144243999 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,144 in 21 payments from 10 companies in 2025. Trend: 2023 $1,008 · 2024 $1,133 · 2025 $1,144
Food & beverage: $1,144
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $328 |
| Novo Nordisk Inc | 4 | $171 |
| SANOFI-AVENTIS U.S. LLC | 3 | $168 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $125 |
| Exact Sciences Corporation | 1 | $122 |
| Alexion Pharmaceuticals, Inc. | 1 | $120 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $55 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $16 |
| Boston Scientific Corporation | 1 | $14 |
Products named: AIRSUPRA, TZIELD, BREZTRI, Ozempic, Kerendia, Cologuard Collection Kit, JARDIANCE, INSPIRE.
Industry payments across NV — which companies pay providers there.
